These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8383771)

  • 1. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
    Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD
    J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human rhinovirus 3 at 3.0 A resolution.
    Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
    Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human rhinovirus serotype 1A (HRV1A).
    Kim SS; Smith TJ; Chapman MS; Rossmann MC; Pevear DC; Dutko FJ; Felock PJ; Diana GD; McKinlay MA
    J Mol Biol; 1989 Nov; 210(1):91-111. PubMed ID: 2555523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
    Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
    Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
    Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
    J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
    Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
    Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
    Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
    Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypsin sensitivity of several human rhinovirus serotypes in their low pH-induced conformation.
    Kowalski H; Maurer-Fogy I; Vriend G; Casari G; Beyer A; Blaas D
    Virology; 1989 Aug; 171(2):611-4. PubMed ID: 2548332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rhinovirus 14 complexed with fragments of active antiviral compounds.
    Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA
    Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of human rhinovirus 16.
    Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
    Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the three-dimensional structure of two human rhinoviruses (HRV2 and HRV14).
    Blaas D; Kuechler E; Vriend G; Arnold E; Luo M; Rossmann MG
    Proteins; 1987; 2(4):263-72. PubMed ID: 2834716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus.
    Phelps DK; Post CB
    Protein Sci; 1999 Nov; 8(11):2281-9. PubMed ID: 10595531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human rhinovirus 14 complexed with antiviral compound R 61837.
    Chapman MS; Minor I; Rossmann MG; Diana GD; Andries K
    J Mol Biol; 1991 Feb; 217(3):455-63. PubMed ID: 1847215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
    Hadfield AT; Diana GD; Rossmann MG
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14730-5. PubMed ID: 10611281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
    Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.
    Hewat EA; Blaas D
    J Virol; 2004 Mar; 78(6):2935-42. PubMed ID: 14990711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
    Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
    J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel benzonitrile analogue inhibits rhinovirus replication.
    Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
    Rossmann MG
    Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
    Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
    J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.